BD To Host Virtual 2025 Annual Meeting of Shareholders
Rhea-AI Summary
BD (NYSE: BDX), a leading global medical technology company, has announced its upcoming 2025 Annual Meeting of Shareholders, which will be held virtually on Tuesday, January 28, 2025, at 1:00 p.m. (ET).
Shareholders of record as of December 9, 2024, or their authorized proxies, will have full participation rights, including the ability to attend, vote, and ask questions during the meeting by accessing the provided virtual platform at https://meetnow.global/M5X7D4A. Guests can also attend in listen-only mode without requiring a control number.
The company will make a replay of the webcast available on the BD website at investors.bd.com for approximately one year following the Annual Meeting.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, BDX gained 0.98%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
As described in the proxy materials for the Annual Meeting previously distributed, shareholders as of the close of business on December 9, 2024, or their duly authorized proxies, will be able to attend and participate in the Annual Meeting, vote their shares and ask questions by visiting https://meetnow.global/M5X7D4A. Guests may also access the Annual Meeting but in listen-only mode. No control number is required for guests.
A replay of the webcast will be available shortly after the Annual Meeting on the BD website at investors.bd.com for approximately one year from the date of the Annual Meeting.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-host-virtual-2025-annual-meeting-of-shareholders-302344823.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
When is BD's (BDX) 2025 Annual Shareholders Meeting?
How can shareholders participate in BD's (BDX) 2025 virtual Annual Meeting?
What is the record date for BD's (BDX) 2025 Annual Meeting?
How long will the replay of BD's (BDX) 2025 Annual Meeting be available?
Can non-shareholders attend BD's (BDX) 2025 Annual Meeting?
